deltatrials
Completed OBSERVATIONAL NCT04516187

Recognition of Serious Infections in the Elderly (ROSIE)

Recognition of Serious Infections in the Elderly: Developing a Diagnostic Prediction Rule Based on Clinical Features and Blood Tests to Help Physicians Safely Rule Out a Serious Infection in an Older Patient Presenting to Ambulatory Care

Sponsor: KU Leuven

Conditions Infection
Updated 8 times since 2020 Last updated: Aug 3, 2023 Started: Oct 16, 2020 Primary completion: Aug 3, 2023 Completion: Aug 3, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04516187, this observational or N/A phase trial focuses on Infection and remains completed. Sponsored by KU Leuven, it has been updated 8 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Sep 2020 – ~Nov 2020 · 2 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotRecruiting~Dec 2021 – ~Feb 2022 · 2 months · monthly snapshot~Feb 2022 – ~Sep 2023 · 19 months · monthly snapshotRecruiting~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Sep 2023 — Jul 2024 [monthly]

    Completed

    Status: RecruitingCompleted

  4. Feb 2022 — Sep 2023 [monthly]

    Recruiting

  5. Dec 2021 — Feb 2022 [monthly]

    Recruiting

Show 3 earlier versions
  1. Jan 2021 — Dec 2021 [monthly]

    Recruiting

  2. Nov 2020 — Jan 2021 [monthly]

    Recruiting

    Status: Not Yet RecruitingRecruiting

  3. Sep 2020 — Nov 2020 [monthly]

    Not Yet Recruiting

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • KU Leuven
Data source: KU Leuven

For direct contact, visit the study record on ClinicalTrials.gov .